Iijima Michihiko, Shimazaki Toshiharu, Ito Akie, Chaki Shigeyuki
Psychiatric Diseases and Pain Research, Medicinal Pharmacology Laboratory, Medicinal Research Laboratories, Taisho Pharmaceutical Co Ltd, Saitama, Japan.
Psychopharmacology (Berl). 2007 Feb;190(2):233-9. doi: 10.1007/s00213-006-0618-6. Epub 2006 Nov 11.
The stress-induced hyperthermia (SIH) test in mice has been widely used as models including some physiological aspects of psychiatric disorders. Mediated by the autonomic nervous system, SIH is commonly known to occur both before and during exposure to stress-inducing or anxiogenic situations. Recently, modulation of the group II metabotropic glutamate (mGlu) 2/3 receptor has been proposed as a novel therapeutic approach for psychiatric disorders.
In the present study, we evaluated the efficacy of selective mGlu2/3 receptor antagonists and an mGlu2/3 receptor agonist in the SIH test.
mGlu2/3 receptor antagonists such as MGS0039 and LY341495 significantly and dose-dependently reduced SIH without affecting basal rectal temperatures. In contrast, mGlu2/3 receptor agonists such as MGS0008 were ineffective in the SIH test. The attenuation of SIH by MGS0039 was significantly blocked by pretreatment with WAY100635, a serotonin 1A receptor antagonist. In contrast, an AMPA receptor potentiator, CX546 failed to reduce the SIH.
Taken together, these results suggest that the blockade of mGlu2/3 receptor may prevent stress-induced autonomic hyperactivity, and that stimulation of the postsynaptic serotonin 1A receptor, but not AMPA receptor, may be involved in this action.
小鼠应激诱导性体温过高(SIH)试验已被广泛用作包括精神疾病某些生理方面的模型。SIH由自主神经系统介导,通常在暴露于应激诱导或焦虑诱发情况之前和期间发生。最近,已提出调节II组代谢型谷氨酸(mGlu)2/3受体作为治疗精神疾病的一种新方法。
在本研究中,我们评估了选择性mGlu2/3受体拮抗剂和mGlu2/3受体激动剂在SIH试验中的疗效。
mGlu2/3受体拮抗剂如MGS0039和LY341495显著且剂量依赖性地降低了SIH,而不影响基础直肠温度。相比之下,mGlu2/3受体激动剂如MGS0008在SIH试验中无效。MGS0039对SIH的减弱作用被5-羟色胺1A受体拮抗剂WAY100635预处理显著阻断。相比之下,AMPA受体增强剂CX546未能降低SIH。
综上所述,这些结果表明,阻断mGlu2/3受体可能预防应激诱导的自主神经功能亢进,并且突触后5-羟色胺1A受体而非AMPA受体的刺激可能参与此作用。